Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Transplantation and Cellular Therapy
|
August 28, 2021
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Bone Marrow Transplantation
|
August 20, 2021
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Transplantation
|
May 21, 2024
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion
Kymberly D Watt, Stacey Rolak, David P Foley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2016
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016
Steven M Horwitz, Andrew D Zelenetz, Leo I Gordon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2016
Diffuse Large B-Cell Lymphoma Version 1.2016
Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Journal of Hematology & Oncology
|
December 16, 2023
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
Julie M Vose, Kai Fu, Lu Wang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Transplantation and Cellular Therapy
|
August 28, 2021
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Bone Marrow Transplantation
|
August 20, 2021
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Transplantation
|
May 21, 2024
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion
Kymberly D Watt, Stacey Rolak, David P Foley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2016
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016
Steven M Horwitz, Andrew D Zelenetz, Leo I Gordon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2016
Diffuse Large B-Cell Lymphoma Version 1.2016
Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Journal of Hematology & Oncology
|
December 16, 2023
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
Julie M Vose, Kai Fu, Lu Wang, et al.
Page
of 6